China Cord Blood sells debt to group controlled by COB

China Cord Blood Corp. (CO +10.1%) agrees to sell its outstanding 7% senior convertible note due 2017 to Magnum Opus International Holdings and large shareholder Cordlife Group Limited for $88.1M.

Magnum Opus is controlled by CO Chairman Yuen Kam. It also involves the CO management team.

The note was originally issued to the company by Golden Meditech in 2012 with an aggregate principal amount of $50M.

From other sites
Comments (1)
  • Accountablecare
    , contributor
    Comments (13) | Send Message
    Gambay! Kam! Going to 10
    26 Aug 2014, 12:19 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs